Company: MYSEW
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001013762-25-004290
Chunk: 1241

Company: Myseum, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 9
Chunk 1241
---
 our management must present information
regarding the related person transaction to our audit committee, or, if audit committee approval would be inappropriate, to another independent
body of our board of directors, for review, consideration and approval or ratification. The presentation must include a description of,
among other things, the material facts, the interests, direct and indirect, of the related persons, the benefits to us of the transaction
and whether the transaction is on terms that are comparable to the terms available to or from, as the case may be, an unrelated third
party or to or from employees generally. Under the policy, we will collect information that we deem reasonably necessary from each director,
executive officer and, to the extent feasible, significant shareholder to enable us to identify any existing or potential related-person
transactions and to effectuate the terms of the policy. In addition, under our code of business conduct and ethics, our employees and
directors will have an affirmative responsibility to disclose any transaction or relationship that reasonably could be expected to give
rise to a conflict of interest. In considering related person transactions, our audit committee, or other independent body of our board
of directors, will take into account the relevant available facts and circumstances including, but not limited to:

    ●
    the risks, costs and benefits to us;

    ●
    the impact on a director’s independence
    in the event that the related person is a director, immediate family member of a director or an entity with which a director is affiliated;

42

    ●
    the availability of other sources for comparable
    services or products; and

    ●
    the terms available to or from, as the case may
    be, unrelated third parties or to or from employees generally.

The policy requires that, in determining whether
to approve, ratify or reject a related person transaction, our audit committee, or other independent body of our board of directors,
must consider, in light of known circumstances, whether the transaction is in, or is not inconsistent with, our best interests and those
of our shareholders, as our audit committee, or other independent body of our board of directors, determines in the good faith exercise
of its discretion.

Independence of the Board of Directors

Our board of directors undertook a review of
the independence of our directors and considered whether any director has a relationship with us that could compromise that director’s
ability to exercise independent judgment in carrying out that director’s responsibilities. Our board of directors has affirmatively
determined